Agilon Health (NYSE:AGL) Shares Down 5.6% – Here’s What Happened

Agilon Health, Inc. (NYSE:AGL) shares dropped 5.6% during trading on Monday . The stock traded as low as $87.45 and last traded at $87.35. Approximately 46,944 shares were traded during trading, a decline of 87% from the average session volume of 347,975 shares. The stock had previously closed at $92.54.

Analyst Upgrades and Downgrades

Several brokerages have commented on AGL. Barclays set a $111.00 price target on shares of Agilon Health and gave the stock an “equal weight” rating in a research report on Thursday, August 6th. Truist Financial set a $112.00 price objective on Agilon Health and gave the company a “hold” rating in a report on Thursday, August 6th. Citigroup raised Agilon Health from a “sell” rating to a “neutral” rating and lifted their target price for the company from $105.00 to $115.00 in a research report on Monday, August 10th. TD Cowen reiterated a “hold” rating and set a $55.00 target price (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Finally, Wells Fargo & Company reissued an “overweight” rating and set a $146.00 price target (up from $141.00) on shares of Agilon Health in a research report on Tuesday, August 11th. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Agilon Health presently has an average rating of “Hold” and an average target price of $97.70.

Agilon Health Trading Down 10.3%

The stock has a market cap of $1.39 billion, a price-to-earnings ratio of -5.82 and a beta of 3.01. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.07. The business’s 50 day simple moving average is $104.11 and its 200 day simple moving average is $63.89.

Agilon Health (NYSE:AGL) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.90. The company had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.45 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. On average, research analysts expect that Agilon Health, Inc. will post -2.33 EPS for the current fiscal year.

Hedge Funds Weigh In On Agilon Health

Hedge funds and other institutional investors have recently bought and sold shares of the business. Rubicon Founders LLC bought a new stake in Agilon Health in the second quarter valued at approximately $11,290,448. Great Lakes Advisors LLC bought a new position in shares of Agilon Health during the 2nd quarter worth approximately $702,000. Alpine Global Management LLC bought a new position in shares of Agilon Health during the 4th quarter worth approximately $84,000. California State Teachers Retirement System bought a new position in shares of Agilon Health during the 2nd quarter worth approximately $1,976,000. Finally, Proficio Capital Partners LLC acquired a new position in shares of Agilon Health during the 2nd quarter worth approximately $210,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.